Filing Details
- Accession Number:
- 0001493152-21-030541
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-06 10:06:10
- Reporting Period:
- 2021-12-03
- Accepted Time:
- 2021-12-06 10:06:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 764195 | Vbi Vaccines Inc | VBIV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1702699 | Nell Beattie | C/O Vbi Vaccines Inc., 160 Second Street Cambridge MA 02142 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value Per Share | Acquisiton | 2021-12-03 | 8,200 | $2.45 | 68,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.4492 to $2.455, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
